期刊文献+

TGF-β_1对骨髓间充质干细胞在无氧无血清条件下凋亡的影响 被引量:3

Effects of TGF-beta1 on Apoptosis of MSCs Treated with Hypoxia Plus Serum Deprivation
暂未订购
导出
摘要 目的:探讨TGF-β1对骨髓间充质干细胞(MSCs)在无氧无血清条件下凋亡的影响。方法:取大鼠骨髓,体外分离,扩增培养MSCs;TGF-β1腺病毒或对照GFP腺病毒转染MSCs。细胞分为TGF-β1-MSCs组、GFP-MSCs组,MSCs组。RT-PCR检测TGF-β1基因的表达;无氧无血清条件下分别诱导各组细胞4,8,12h,流式细胞仪检测凋亡变化;RT-PCR检测bcl-2 mRNA的表达。结果:TGF-β1转染的MSCs表达TGF-β1基因水平与GFP-MSCs组,MSCs组相比均增加(P<0.05);细胞在无氧无血清条件下诱导4,8,12h,后TGF-β1-MSCs组的凋亡率与GFP-MSCs组,MSCs组的凋亡率相比降低(P<0.05),且随时间的推移呈升高的趋势(P<0.05);bcl-2 mRNA在无氧无血清条件下诱导4,8,12h后的表达水平TGF-β1-MSCs与GFP-MSCs、MSCs相比均增加(P<0.05),且随时间的推移均呈降低趋势(P<0.05)。结论:TGF-β1修饰的MSCs可稳定高效表达TGF-β1基因;TGF-β1-MSCs通过上调bcl-2 mRNA水平抑制无氧无血清诱导的凋亡。 Objective: To investigate the effects of TGF-β1 on the levels of apoptosis of MSCs treated with hypoxia plus serum deprivation. Methods: MSCs were cultured in vitro, and transfected by Adv-TGF-β1 or Adv-GFP. RT-PCR was used to determine the expression of TGF-β1. FACS was used to determined the apoptosis of MSCs under the condition of hypoxia plus serum deprivation at 4, 8 and 12 h, respectively, and RT-PCR was used to determine the expression of bcl-2 mR- NA. Results: TGF-β1-MSCs exhibited increased TGF-β1 expression. The levels of apoptosis at 4, 8 and 12 h after treatment with hypoxia plus serum deprivation were all significantly decreased in TGF-β1-MSCs than those in GFP-MSCs and MSCs, and increased with time. The levels of bcl-2 mRNA expression at 4, 8 and 12 h were all significantly decreased in TGF-β1-MSCs than those in GFP-MSCs and MSCs, and decreased with time. Conclusion: TGF-β1-MSCs exhibited increased TGF-β1 expression, and decreased the levels of apoptosis of MSCs treated with hypoxia plus serum deprivation by upregulating bcl-2 mRNA.
出处 《武汉大学学报(医学版)》 CAS 2007年第6期729-732,共4页 Medical Journal of Wuhan University
关键词 骨髓间充质干细胞 TGF-Β1 凋亡 缺氧 Mesenchymal Stem Cells TGF-β1 Apoptosis Hypoxia
  • 相关文献

参考文献8

  • 1Hassink RJ, Brutel de la Riviere A, Mummery CL, et al. Transplantation of cells for cardiac repair[J]. J Am Coll Cardiol,2003,41(5):711-717.
  • 2Pittenger MF, Martin BJ. Mesenchymal stem cells and their protential as cardiac therapeutics [J]. Circulat Res, 2004,95:9-20.
  • 3Gencchi M, He HM, Noiseux N, et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement[J]. FASEB J, 2006, 20: 661-669.
  • 4Kolb M,Bonniaud P, Gait T,et al. Differences in the fibrogenic response after transfer of active transforming growth factor-β1 gene tolungs of fibrosis prone and fibrosis resistant mouse strains[J]. Am J Respir Cell Mol Biol, 2002,27:141-150.
  • 5Wollert KC, Helmut Drexler H. Mesenchymal stem cells for myocardial infarction promises and pitfalls[J]. Circulation, 2005,112:151-153.
  • 6Zhan Q, Korsmer SJ. Inhibitory effect of Bcl-2 on P53-mediated transactivation following genotoxia stress[J]. Oncogene, 1999,18(2) :297-304.
  • 7Shake JG, Gruber PJ,Baumgartner WA, et al. Meaenchymal stem cell implantation in a swine myocardial infarct model, engraftment and functional effects [J]. Ann Thorac Surg, 2002,73(6):1917-1925.
  • 8Toma C, Pittenger MF, Cahill KS, et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart [J]. Circulation, 2002, 105: 93-98.

同被引文献55

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部